News | February 07, 2022
Caplin Point’s Q3 in line; outlook positive amid expansion plans: ICICI Direct
Key takeaways of recent quarter & conference call highlights
Key takeaways of recent quarter & conference call highlights
Pfizer and Moderna are also working on vaccines that target the Omicron variant
A National Tele Mental Health Programme is being launched to address mental health issues. We spoke to healthcare industry leaders who shared their outlook
The award was given as a result of NASSCOM's meticulous screening process, in which over 700 start-ups were shortlisted as the most promising companies of the year
Merck is studying the Complete Response Letter and it is not related to the safety of gefapixant
Go-ahead for pivotal clinical trial which is expected to commence by March
It is the first CAR T Therapy approved for the treatment of multiple myeloma in Japan
The acquisition would enable addition of established brands with high recall amongst healthcare professionals, especially in the vitamins, minerals and supplements category
Prof Karikó's research was most notably used by Pfizer/BioNTech and Moderna to build COVID-19 mRNA vaccines
The latest research results indicated that JMB2002 had high binding activity to the Omicron variant and showed potent Omicron pseudovirus neutralization function
Subscribe To Our Newsletter & Stay Updated
